Medications for Head And Neck Squamous Cell Carcinoma

7 results

  • Beizray (docetaxel)

    (Docetaxel)
    Zhuhai Beihai Biotech Co., Ltd.
    Usage: BEIZRAY, in combination with cisplatin and fluorouracil, is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).

  • Bleomycin (bleomycin sulfate)

    (BLEOMYCIN SULFATE)
    Fresenius Kabi USA, LLC
    Usage: Bleomycin for Injection, USP is indicated for palliative treatment of various neoplasms, including squamous cell carcinoma (head and neck, penis, cervix, vulva), lymphomas (Hodgkin's and non-Hodgkin's), and testicular carcinoma (embryonal cell, choriocarcinoma, teratocarcinoma). It also helps manage malignant pleural effusion.

  • Hydroxyurea (hydroxyurea)

    (HYDROXYUREA)
    REMEDYREPACK INC.
    Usage: Hydroxyurea capsules are indicated for the treatment of resistant chronic myeloid leukemia and locally advanced squamous cell carcinomas of the head and neck (excluding the lip) in combination with chemoradiation.

  • Hydroxyurea (hydroxyurea)

    (Hydroxyurea)
    Teva Pharmaceuticals USA, Inc.
    Usage: Hydroxyurea capsules are indicated for treating resistant chronic myeloid leukemia and for use in combination with chemoradiation for locally advanced squamous cell carcinomas of the head and neck (excluding the lip).

  • Hydroxyurea (hydroxyurea)

    (Hydroxyurea)
    REMEDYREPACK INC.
    Usage: Hydroxyurea capsules are indicated for treating resistant chronic myeloid leukemia and locally advanced squamous cell carcinomas of the head and neck (excluding the lip) when used in combination with chemoradiation.

  • Isoniazid (isoniazid)

    (Isoniazid)
    Chartwell RX, LLC
    Usage: Isoniazid oral solution is indicated for treating all forms of susceptible tuberculosis, requiring multi-drug therapy to prevent resistance. It is also used for preventive therapy in high-risk groups, including HIV-infected individuals and close contacts of infectious cases, among others, to reduce tuberculosis incidence.

  • Methotrexate (methotrexate)

    (Methotrexate)
    Accord Healthcare, Inc.
    Usage: Methotrexate Injection is indicated for treating various conditions, including acute lymphoblastic leukemia, meningeal leukemia, Non-Hodgkin lymphoma, osteosarcoma, breast cancer, squamous cell carcinoma of the head and neck, gestational trophoblastic neoplasia, rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and severe psoriasis.